Tower Research Capital (TRC)’s Jupiter Neurosciences JUNS Stock Holding History
Bought
Maintained
Sold
Other funds holding JUNS
Tower Research Capital (TRC)'s JUNS Position: Q3 2026 in Review
Tower Research Capital (TRC) sold out of Jupiter Neurosciences (JUNS) in Q3 2026, closing a stake of 384 shares — an estimated $6.17K sold.
Tower Research Capital (TRC) first reported a position in JUNS in Q2 2026 and held it in 1 quarter. The position peaked at $6.17K in Q2 2026. 8 funds tracked by Wall St. Rank hold JUNS as of Q3 2026.
- Tower Research Capital (TRC) reported no remaining Jupiter Neurosciences position as of Q3 2026 after selling out during the quarter.
- Tower Research Capital (TRC) sold 384 Jupiter Neurosciences shares in Q3 2026, an estimated $6.17K.
- Tower Research Capital (TRC) first reported a position in Jupiter Neurosciences in Q2 2026 and held it in 1 quarter.
- Tower Research Capital (TRC)'s Jupiter Neurosciences position peaked at $6.17K in Q2 2026.
- 8 funds tracked by Wall St. Rank held Jupiter Neurosciences as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.